Artemis Medicare Services Ltd Share Price

Overview

Artemis Medicare Services Ltd share price is currently ₹323.59, up by ₹2.27 (0.71%) from its previous closing price of ₹321.32. The share price has gained 18.21% over the past month and gained 37.29% over the past year. The stock's 52-week low and high are ₹199.94 and ₹329.04, respectively. Artemis Medicare Services Ltd has a market capitalisation of ₹ 5,160.00 Cr. The share price was last updated on 26 Aug 2026, 03:29 PM IST.

Artemis Medicare Services Ltd
Artemis Medicare Services Ltd
ARTEMISMED
 0.00
 2.27
0.71%
Healthcare
 0.00(%)1D

Updated: 26 Aug 2026, 03:29:58 pm IST

Market Data

Open Price

 323.54

Prev. Close

 321.32
 319.44

Day Low

 325.32

Day High

 199.94

52 Week Low

 329.04

52 Week High

HealthcareHospital & Healthcare Services
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

43.49

Sector PE

42.03

PB Ratio

5.92

Sector PB

5.82

EPS

7.44

Dividend Yield

0.22

Today's Volume

155.554 K

5 Day Avg. Volume

508.661 K

PEG Ratio

4.83

Market Cap.

₹ 5,160.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 45% at ₹0.45/Share
10-Jul-202610-Jul-2026
DividendsFinal Dividend of 45% at ₹0.45/Share
11-Jul-202511-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
HSBC Focused Fund - Regular Plan - Growth12.50 Lac
12.50 Lac
no change
Bandhan Small Cap Fund - Regular Plan - Growth6.10 Lac
6.10 Lac
no change
JM ELSS Tax Saver Fund - Growth-
1.02 Lac
(100%)
LIC MF Healthcare Fund - Regular Plan - Growth93.53 k
93.53 k
no change
Groww BSE Hospitals ETF12.98 k
26.23 k
(102.13%)

About Artemis Medicare Services Ltd 👋

Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (hematology), bones, muscles and joints (orthopedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and cardiology, infectious diseases, sleep apnea, kidneys stone treatment and failure (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynecology, psychiatry, arthritis and joint disease, surgery, and urology. It also offers treatment for irregular periods, vertigo, finger joint treatment, and piles. The Company's subsidiary includes Artemis Cardiac Care Private Limited.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Manish Salvi

Manish Salvi

3 Aug • 9:59 AM · SEBI-Registered Analyst

MOMENTUM MANTRA DAILY RUN-UP 📅 03 August 2026

MOMENTUM MANTRA DAILY RUN-UP Opening View Indian markets are likely to open on a *strongly positive note, with **GIFT Nifty trading near 24,629, up 175.90 points (+0.72%). Strong global cues, robust U.S. technology-led gains, and sustained FII buying are likely to support sentiment. Market Recap Indian equity benchmarks ended higher, supported by gains in Auto, Capital Goods, and Industrials stocks. Strong global market momentum, robust Q1FY27 earnings, and sustained FII inflows kept sentiment positive, while profit booking in IT stocks and ongoing Middle East geopolitical tensions capped the overall gains. Nifty Key Levels ▪️ Support: 24,250 | 24,130 ▪️ Resistance: 24,460 | 24,530 FII/DII Flow ▪️ FII: +₹277.48 crore ▪️ DII: +₹2,260.37 crore Options Positioning ▪️ PCR: 1.39 (Strong Bullish) – Higher Put OI than Call OI indicates aggressive Put writing and a strong positive near-term bias. ▪️ Resistance: *24,500–24,700* zone, with the highest Call OI concentration at *24,600, followed by **24,700* and *24,500*. ▪️ Support: *24,400–24,300* zone, backed by strong Put OI buildup, with the highest Put OI at *24,400, followed by **24,300* and *24,350*. ▪️ Max Pain: *24,350* – Indicates *24,350* as the equilibrium level for the current weekly expiry. ▪️ Interpretation: PCR at 1.39 reflects a *strong bullish undertone, with Put writers firmly defending the **24,350–24,400* zone. As long as Nifty sustains above *24,350, the positive bias is likely to continue. A decisive move above **24,500* could trigger fresh buying toward *24,600–24,700, while a break below **24,350* may lead to profit booking toward *24,200–24,100*. Source: NSE India Sectoral Outlook 🟢 Bank Nifty – Buy on Dips 🟢 PSU Bank – Buy on Dips 🟢 Metal – Buy on Dips 🟢 Energy – Buy on Dips 🟢 Pharma – Buy on Dips 🟢 Auto – Accumulate 🟡 Realty – Stock Specific Stocks In NEWS

ARTEMISMED
PARKHOSPS
MUTHOOTFIN
NATIONALUM
HBLENGINE
⚠️For informational purposes only. Not investment advice

See More
AALGO BREATHS I SEBI RA

AALGO BREATHS I SEBI RA

4 Feb • 11:50 PM · SEBI-Registered Analyst

Artemis Medicare Services Latest Updates

ARTEMISMED
Q3 FY26 Financial Performance Revenue and Profit Growth: For the quarter ended December 31, 2025, Artemis reported consolidated revenue of ₹272.35 crore, a 17.2% year-on-year (YoY) increase. Net profit (PAT) rose 7.9% YoY to ₹22.23 crore, supported by a sharp 40.8% sequential jump from the previous quarter. Operational Efficiency: Average Revenue Per Occupied Bed (ARPOB) grew by 10% YoY to ₹84,100. This was primarily driven by a surge in high-margin international patient revenue, which grew 34.9% and now contributes 34% of the total net revenue. Labor Code Impact: The company recognized an exceptional item of ₹3.07 crore during the quarter due to the impact of new Labour Codes, which influenced wage definitions and employee benefits. Aggressive Expansion & Fundraising ₹700 Crore Capital Raise: On February 2, 2026, the Board approved a fundraise of up to ₹700 crore through equity, convertible debentures, or a Qualified Institutions Placement (QIP). These funds are earmarked for long-term expansion and debt management. Capacity Triple-Up: The hospital group plans to scale its bed capacity from the current ~700 to 2,000 beds by 2028. The Gurugram flagship facility alone is set to expand to 1,000 beds, aided by a 15% increase in Floor Area Ratio (FAR) granted for its Platinum Green Building Certification. New Facilities: Construction of a 300+ bed super-specialty hospital in Raipur is advancing as planned, with operations expected to commence by April or May 2026. Stock & Market Context Price Volatility: Despite the robust operational results, the stock saw a sharp decline of over 8.5% on February 4, 2026, dropping to approximately ₹219. This follow-through selling has put the stock on a three-day losing streak, possibly due to market skepticism regarding near-term return ratios (ROE).

See More
Sneha Jain

Sneha Jain

18 Sep • 12:17 PM · SEBI-Registered Analyst

ARTEMIS MEDICARE: NEW HEAD APPOINTED

Appointment: Rudra Narayan Acharjee named Head – Investor Relations, M&A & Growth Strategy Experience: 15+ years across healthcare, manufacturing & banking; ex-KIMS, Narayana Health, Fortis Role Focus: Strengthen investor relations, drive M&A pipeline, support long-term growth strategy Impact: Adds seasoned leadership in strategy & finance, expected to enhance growth momentum & investor confidence.

ARTEMISMED

See More

News & Events

Frequently Asked Questions

What is the share price of Artemis Medicare Services Ltd?

What is the market cap of Artemis Medicare Services Ltd?

Should I buy Artemis Medicare Services Ltd stock now?

What is the 52 week high and low of Artemis Medicare Services Ltd?

Is the Artemis Medicare Services Ltd stock good to buy?

Is Artemis Medicare Services Ltd a good buy for the long term?

Is Artemis Medicare Services Ltd overvalued or undervalued?

What is the PE and PB ratio of Artemis Medicare Services Ltd?

Start Now